Peoples Bank OH Has $291,000 Position in MetLife, Inc. (NYSE:MET)

Peoples Bank OH decreased its holdings in shares of MetLife, Inc. (NYSE:MET) by 27.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,531 shares of the financial services provider’s stock after selling 1,363 shares during the period. Peoples Bank OH’s holdings in MetLife were worth $291,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in MET. Bogart Wealth LLC increased its stake in shares of MetLife by 0.3% in the 3rd quarter. Bogart Wealth LLC now owns 80,815 shares of the financial services provider’s stock valued at $6,666,000 after acquiring an additional 261 shares in the last quarter. Impact Partnership Wealth LLC raised its holdings in shares of MetLife by 1.6% during the third quarter. Impact Partnership Wealth LLC now owns 10,249 shares of the financial services provider’s stock valued at $845,000 after purchasing an additional 160 shares during the period. Romano Brothers AND Company raised its holdings in shares of MetLife by 3.3% during the third quarter. Romano Brothers AND Company now owns 54,514 shares of the financial services provider’s stock valued at $4,496,000 after purchasing an additional 1,727 shares during the period. Litman Gregory Wealth Management LLC acquired a new stake in shares of MetLife in the 3rd quarter valued at about $247,000. Finally, Greenleaf Trust increased its position in MetLife by 0.4% in the 3rd quarter. Greenleaf Trust now owns 31,393 shares of the financial services provider’s stock valued at $2,589,000 after buying an additional 139 shares in the last quarter. Institutional investors and hedge funds own 89.81% of the company’s stock.

MetLife Price Performance

Shares of NYSE MET opened at $84.36 on Friday. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.56. The company has a market capitalization of $59.99 billion, a PE ratio of 28.99, a PEG ratio of 0.69 and a beta of 1.04. The stock’s 50 day moving average price is $79.37 and its 200-day moving average price is $74.36. MetLife, Inc. has a twelve month low of $57.91 and a twelve month high of $86.94.

MetLife (NYSE:MET) last announced its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $2.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.13 by $0.15. MetLife had a return on equity of 21.41% and a net margin of 4.23%. The firm had revenue of $17.82 billion during the quarter, compared to the consensus estimate of $18.57 billion. During the same quarter in the prior year, the company earned $1.94 EPS. The business’s revenue for the quarter was up 7.2% on a year-over-year basis. On average, equities analysts anticipate that MetLife, Inc. will post 8.61 EPS for the current year.

MetLife Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be issued a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, November 5th. This represents a $2.18 dividend on an annualized basis and a yield of 2.58%. MetLife’s dividend payout ratio (DPR) is presently 74.91%.

Analysts Set New Price Targets

Several research analysts have issued reports on MET shares. Piper Sandler increased their price target on MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. StockNews.com cut MetLife from a “buy” rating to a “hold” rating in a report on Friday, October 4th. Barclays began coverage on shares of MetLife in a research note on Wednesday, September 4th. They set an “overweight” rating and a $91.00 price target for the company. Jefferies Financial Group raised their price objective on shares of MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research note on Friday, September 27th. Finally, TD Cowen initiated coverage on shares of MetLife in a research report on Wednesday, October 9th. They set a “buy” rating and a $97.00 target price for the company. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $88.46.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.